Sanofi and Google will establish a virtual innovation lab to tap emerging data technologies.
Under the project, both companies will use deep analytics to better understand key diseases and extract related patient insights, allowing Sanofi to develop more personalised approaches to treatment.
The innovation lab is expected to help transform the delivery of future medicines. The collaboration will improve the understanding of diseases, increase Sanofi’s operational efficiency, and improve the experience of Sanofi’s patients and customers.
The companies will use Sanofi’s database to understand what treatments work for patients. The objective is to improve personalised treatment, optimise patient care and reduce healthcare costs.
Sanofi chief digital officer, chief medical officer and executive vice-president of medical Ameet Nathwani said: “We stand on the forefront of a new age for biology and human health, with the opportunity to transform healthcare through partnerships with pioneering technology and analytics companies.
“Combining Sanofi’s biologic innovations and scientific data with Google’s industry-leading capabilities, from Cloud computing to state-of-the-art artificial intelligence, we aspire to give people more control over their health and accelerate the discovery of new therapies.”
Sanofi and Google intend to use artificial intelligence (AI) across datasets to forecast sales and inform marketing and supply chain efforts. By using AI, the companies will be able to take into account real-time information, including geographic, logistic and manufacturing constraints to help the accuracy of these activities.
Sanofi IT will migrate some business applications to the Google Cloud platform. The company intends to accelerate and simplify legacy management while providing easy integration into business plans via automation, scalability and agility.
The transition to the Google Cloud platform is expected to maximise operational cost efficiency and support business objectives, including the innovation lab.
Google Cloud CEO Thomas Kurian said: “Life sciences companies are looking to data-driven, digital innovation to help fuel the creation of accessible healthcare solutions. We look forward to collaborating with Sanofi to help accelerate the cycle of healthcare innovation to populations throughout the world.”